منابع مشابه
Prioritisation of System Changes using Cost-Benefit and Risk Assessments
This paper proposes an approach to the prioritisation of system changes that takes account of the relative costs and benefits of those changes and the risks that they reduce or introduce. This is part of the SERUM methodology (Software Engineering Risk: Understanding and Management), which is being developed to help identify effective ways of using risk analysis and control in software producti...
متن کاملThe critical role of risk-benefit assessments in cancer prevention.
Controversy is building around agent development for cancer prevention. The withdrawal of rofecoxib (Vioxx, Merck) from the market and safety concerns raised by studies of other cyclooxygenase-2-selective inhibitors and an over-the-counter nonsteroidal anti-inflammatory drug have alarmed patients, physicians, and regulatory authorities. Evidence of nonsteroidal anti-inflammatory drug–associated...
متن کاملThe potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent
There has been considerable debate surrounding the ethics of sham-controlled trials of procedures and interventions. Critics argue that these trials are unethical because participants assigned to the control group have no prospect of benefit from the trial, yet they are exposed to all the risks of the sham intervention. However, the placebo effect associated with sham procedures can often be su...
متن کاملColony-stimulating factor use in the context of refined risk and benefit assessments.
Chemotherapy-induced neutropenia (CIN) is the primary dose-limiting toxicity in patients being treated for cancer. The substantial toll of CIN includes febrile neutropenia (FN), hospitalization, infection, early mortality, increased medical costs, decreased quality of life, and the potential for diminished long-term survival due to chemotherapy dose reductions and delays.[1] The advent of colon...
متن کاملBenefit‐Risk Assessment Methods in Medical Product Development: Bridging Qualitative and Quantitative Assessments
Reviewed by Jeffry Florian* and Ada Zhuang Benefit-risk assessments, which evaluates the benefits of a medical product, device, or intervention, as well as its associated risks, is increasingly utilized to assist in decision making at regulatory agencies, within pharmaceutical companies, and by clinical practitioners. At its core, benefit-risk is about trade-offs – trying to understand the type...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Dental Journal
سال: 2011
ISSN: 0007-0610,1476-5373
DOI: 10.1038/sj.bdj.2011.101